Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic

Toshimitsu HamasakiThe George Washington University Biostatistics Center, Rockville, MD; Correspondence[email protected]

Frank BretzClinical Development & Analytics, Novartis Pharma, Basel, Switzerland; ;Section for Medical Statistics, Medical University of Vienna, Vienna, Austria;

Freda CoonerStatistical Innovation, Amgen, Thousand Oaks, CA;

Lisa M. LaVangeDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC

Martin PoschSection for Medical Statistics, Medical University of Vienna, Vienna, Austria;

http://orcid.org/0000-0001-8499-8573

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Toshimitsu Hamasaki. (2022) Editor’s Note. Statistics in Biopharmaceutical Research 14:2, pages 139-139.
Read now

Freda Cooner, Toshimitsu Hamasaki, Frank Bretz, Gene Pennello & Martin Posch. (2022) Statistical Issues and Challenges in Clinical Trials for COVID-19 Treatments, Vaccines, Medical Devices and Diagnostics. Statistics in Biopharmaceutical Research 14:1, pages 1-2.
Read now

Articles from other publishers (2)

Matthias J. Koepp, Eugen Trinka, Yee‐Haur Mah, Carla Bentes, Susanne Knake, Gian Luigi Gigli, José M. Serratosa, Johan Zelano, Luís M. Magalhães, Ana Pereira, Joana Moreira & Patrício Soares‐da‐Silva. (2023) Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate. Epilepsia Open.
Crossref

Florian Lasch & Lorenzo Guizzaro. (2022) Estimators for handling COVID ‐19‐related intercurrent events with a hypothetical strategy . Pharmaceutical Statistics 21:6, pages 1258-1280.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic

Citations (4)

Read on this site (2)

Articles from other publishers (2)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date